Have multiple conditions? Click here

New Clinical Trials for Irritable Bowel Syndrome (IBS)

If you suffer from irritable bowel syndrome chances are you spend many days being uncomfortable and missing work because of your condition. Although there is a large body of irritable bowel syndrome clinical research, not much is known about the disease. While some suspect it is the result of a yet to be discovered infection others believe there is a mind/body connection. There is no known cause, no clear diagnosis method and no cure. There are ongoing irritable bowel syndrome clinical trials being conducted.
 

What is Irritable Bowel Syndrome (IBS)?

Irritable bowel syndrome (IBS) is also sometimes called spastic colon. Irritable bowel syndrome is diagnosed when no specific cause can be found for a condition that involves chronic pain in the abdomen, bloating and abnormal bowel habits. There are several classifications of IBS – constipation predominant (IBS-C), diarrhea predominant (IBS-D) and alternating between the two (IBS-A). The cause of irritable bowel syndrome is not known. Some believe it is a disorder where the brain and the gastrointestinal tract have trouble communicating. Others believe it is a psychological disease resulting from stress.
 

Irritable Bowel Syndrome (IBS) Treatments

Irritable bowel syndrome was first documented as such around 1950. Many tests have been done on diet and how this might affect a person suffering from IBS. In some patients restricting their diet of lactose or fructose has helped in treating irritable bowel syndrome. Taking in more soluble fiber has also proven effective. Depending on the type of IBS different medications like laxatives or antispasmodics can be prescribed. Psychotherapy including cognitive behavior therapy and hypnosis has been effective in treating irritable bowel syndrome. As a last resort for the treatment of irritable bowel syndrome tricyclic antidepressants are sometimes prescribed.

Have multiple conditions? Click here

Showing 1-100 of 413
There are 413 Irritable Bowel Syndrome (IBS) Clinical Trials
Name City State Zip
Irritable Bowel Syndrome (IBS) Clinical Trial Birmingham AL 35216
Irritable Bowel Syndrome (IBS) Clinical Trial Port Orange FL 32129
Irritable Bowel Syndrome (IBS) Clinical Trial DeLand FL 32720
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Huntsville AL 35801
Study of CB-183,315 in Patients With Clostridium Difficile Infection Dothan AL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Dothan AL 36305
Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry Birmingham AL 35294
Observational Study of Control Participants for the MAPP Research Network Birmingham AL 35233
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Birmingham AL 35215
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Birmingham AL 35242
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Birmingham AL 35242
Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Irritable Bowel Syndrome With Diarrhea Anniston AL 36207
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Tucson AZ 85741
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Tucson AZ 85715
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Tucson AZ 85741
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Tucson AZ 85712
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Tucson AZ 85721
Intestinal Microecology in Chronic Constipation Scottsdale AZ 85259
Trial Comparing Neomycin to Rifaximin Plus Neomycin in the Treatment of Methane Positive Subjects With Constipation Predominant Irritable Bowel Syndrome (C-IBS) Scottsdale AZ 85259
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Scottsdale AZ 85260
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Phoenix AZ 85050
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Phoenix AZ 85206
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Sherwood AR 72120
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Little Rock AR 72205
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea Little Rock AR
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Little Rock AR 72205
Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Irritable Bowel Syndrome With Diarrhea Jonesboro AR 72401
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Westlake Village CA 91361
Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Irritable Bowel Syndrome With Diarrhea West Lake Village CA 91361
Curcumin (Tumeric) in the Treatment of Irritable Bowel Syndrome: A Randomized-Controlled Trial Vallejo CA 94589
Observational Study of Control Participants for the MAPP Research Network Stanford CA 94305
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea Santa Clara CA 95051
Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults Santa Clara CA 95051
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease San Francisco CA 94115
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) San Fernando Valley CA 91505
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) San Diego CA 92108
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) San Diego CA 92123
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) San Diego CA 92120
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) San Diego CA 92103
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) San Carlos CA 94070
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Sacramento CA 95816
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Orange CA 92868
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Orange CA 92868
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Madera CA 93637
Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease Los Angeles CA 90027
Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain Los Angeles CA 90027
Trial Comparing Neomycin to Rifaximin Plus Neomycin in the Treatment of Methane Positive Subjects With Constipation Predominant Irritable Bowel Syndrome (C-IBS) Los Angeles CA 90048
The Effect of Lubiprostone on Patterns of Contractions in the Small Bowel in Female Patients With Constipation Irritable Bowel Syndrome (C-IBS) Los Angeles CA 90048
Observational Study of Control Participants for the MAPP Research Network Los Angeles CA 90033
Iyengar Yoga for Young People With Irritable Bowel Syndrome Los Angeles CA 90064
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents Los Angeles CA 90095
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Lomita CA 90717
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease La Jolla CA 92093
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Garden Grove CA 92840
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Foothill Ranch CA 92610
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Foothill Ranch CA 92610
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Encinitas CA 92024
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Chula Vista CA 91911
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Chula Vista CA 91910
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Beverly Hills CA 90211
Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Irritable Bowel Syndrome With Diarrhea Anaheim CA 92801
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Wheat Ridge CO 80033
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Pueblo CO 81007
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) LaFayette CO 80026
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Colorado Springs CO 80907
Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Irritable Bowel Syndrome With Diarrhea Colorado Springs CO 80907
Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Irritable Bowel Syndrome With Diarrhea Colorado Springs CO 80922
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Colorado Springs CO 80918
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Waterbury CT 06708
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Torrington CT 06790
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea Newington CT
Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults Newington CT
Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry Hartford CT 06106
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Darien CT 06820
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Danbury CT 06810
Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Irritable Bowel Syndrome With Diarrhea Bristol CT 06010
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Bridgeport CT 06606
Study of CB-183,315 in Patients With Clostridium Difficile Infection Washington
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Winter Park FL 32792
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) St Petersburg FL 33709
Study of CB-183,315 in Patients With Clostridium Difficile Infection St Cloud FL 34769
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Port Orange FL 32129
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Port Orange FL 32129
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Palm Harbor FL 34684
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Orlando FL 32806
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Orlando FL 32806
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Orlando FL 32833
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease Miami FL 33136
Study of CB-183,315 in Patients With Clostridium Difficile Infection Miami FL 33175
Observational Study of Control Participants for the MAPP Research Network Miami FL 33136
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Lake Worth FL 33449
Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry Jacksonville FL 32207
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Jacksonville FL 32256
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Hollywood FL 33021
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Hialeah FL 33012
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS): The Search for New Genes Gainesville FL 32610
LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) DeLand FL 32720
Mesalamine Granules for Irritable Bowel Syndrome (IBS) With Diarrhea Celebration FL
Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults Celebration FL
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS) Cape Coral FL 33904

Showing 1-100 of 413
Alabama - Alaska - Arizona - Arkansas - California - Colorado - Connecticut - Delaware - Washington DC - Florida - Georgia - Hawaii - Idaho - Illinois - Indiana - Iowa - Kansas - Kentucky - Louisiana - Maine - Maryland - Massachusetts - Michigan - Minnesota - Mississippi - Missouri - Montana - Nebraska - Nevada - New Hampshire - New Jersey - New Mexico - New York - North Carolina - North Dakota - Ohio - Oklahoma - Oregon - Pennsylvania - Rhode Island - South Carolina - South Dakota - Tennessee - Texas - Utah - Vermont - Virginia - Washington - West Virginia - Wisconsin - Wyoming
For Sponsors: Promote Your Study | For Research Sites: Promote Your Site

Copyright 2012 Clinical Trials Institute, LLC | All Rights Reserved
Login
Forgot password?
Enter your email and we will resend your password
Register